Change search criteria ↓

Search results

16 projects found matching your search criteria:

  1. 1. Biased inverse agonists of 5-HT6 receptor and dual 5-HT6/MAO-B inhibitors - in search for new therapeutic approaches for…

    Principal investigator: prof. Paweł Maria Zajdel

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 11, Panel: NZ7

  2. 2. 5-HT6 receptor ligands as addition to antipsychotic therapy in schizophrenia - an impact on body weight, metabolic param…

    Principal investigator: prof. Anna Małgorzata Wesołowska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 10, Panel: NZ7

  3. 3. Thymol-derived 1,3,5-triazines, the non-indole and non-sulfone 5-HT6 receptor ligands, as a starter in search for an inn…

    Principal investigator: prof. Jadwiga Handzlik

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 16, Panel: NZ7

  4. 4. Traizine 5-HT6 receptor ligands - new perspective for therapy of current civilization CNS-diseases

    Principal investigator: dr hab. Jadwiga Handzlik

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 9, Panel: NZ7

  5. 5. First-in-class dual modulators of necroptosis kinases and 5-HT6 receptors as an innovative approach to develop an effect…

    Principal investigator: prof. Jadwiga Handzlik

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 26, Panel: NZ7

  6. 6. Neuroprotective properties of 5-HT6 receptor ligands in the group of 2-arylpyrrole derivatives – a new insight into neur…

    Principal investigator: Marcin Józef Drop

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 17, Panel: NZ7

  7. 7. Unusual 5-HT6 receptor ligands

    Principal investigator: prof. Andrzej Jacek Bojarski

    Instytut Farmakologii PAN

    Call: OPUS 7, Panel: NZ7

  8. 8. Combination of FAAH inhibition with action via serotonin 5-HT6 receptor as pioneering approach to fight with Alzheimer D…

    Principal investigator: Kinga Maria Czarnota-Łydka

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 21, Panel: NZ7

  9. 9. New 5-HT6 receptor ligands from the group of sulfonamide derivatives of cyclic arylguanidines in the treatment of gliobl…

    Principal investigator: dr Przemysław Patryk Zaręba

    Politechnika Krakowska im. Tadeusza Kościuszki, Wydział Inżynierii i Technologii Chemicznej

    Call: PRELUDIUM 19, Panel: NZ7

  10. 10. Towards innovative strategy for treatment of Alzheimer's Disease via dual inhibition of receptor 5-HT6 and kinase CDK5.

    Principal investigator: Sylwia Sudoł-Tałaj

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 19, Panel: NZ7

  11. 11. Novel multi-target directed ligands combining cholinesterase inhibition and 5-HT6 antagonism - design, synthesis and pha…

    Principal investigator: dr hab. Anna Karolina Więckowska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: SONATA 12, Panel: NZ7

  12. 12. Novel hybrid 5-HT6 serotonin receptor and SERT transporter ligands as a therapeutic perspective of behavioural and cogni…

    Principal investigator: dr Agata Siwek

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: SONATA 14, Panel: NZ7

  13. 13. The determination of ADME-Tox in vitro for potential CNS-drug candidates acting as potent and selective ligands of serot…

    Principal investigator: Annamaria Teresa Lubelska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: PRELUDIUM 11, Panel: NZ7

  14. 14. Dual 5-HT3 receptor/5-HT6 receptor antagonists in neuropsychiatric and neurological disorders

    Principal investigator: prof. Paweł Maria Zajdel

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 22, Panel: NZ7

  15. 15. Dual-acting 5-HT6/5-HT7 receptor antagonists: exploring beneficial effects for the treatment of neurodegenerative disord…

    Principal investigator: Michał Kamiński

    Uniwersytet Jagielloński

    Call: PRELUDIUM 24, Panel: NZ7

  16. 16. NMR Spectroscopy as Molecular Language: A Deep Learning Approach to Bioactivity Prediction

    Principal investigator: Arkadiusz Bogumił Leniak

    Instytut Farmakologii PAN

    Call: PRELUDIUM 24, Panel: NZ7

Graphic design and implementation: Jakub Piotrowski